Early Treatment and HIV-1 Reservoirs: A Stitch in Time?

Henrich, Timothy J.; Gandhi, Rajesh T.
October 2013
Journal of Infectious Diseases;Oct2013, Vol. 208 Issue 8, p1189
Academic Journal
The article presents the author's comments on the implications of antiretroviral therapy (ART) during acute human immunodeficiency virus type 1 (HIV-1) infection on viral reservoirs. It specifically refers to a study which examined HIV-1 nucleic acid levels and T-cell activation in patients who started ART within six months from the time of infection to those who started therapy two years after infection.


Related Articles

  • Low-Level Viremia and Proviral DNA Impede Immune Reconstitution in HIV-1--Infected Patients Receiving Highly Active Antiretroviral Therapy. Ostrowski, Sisse R.; Katzenstein, Terese L.; Thim, Per T.; Pedersen, Bente K.; Gerstoft, Jan; Ullum, Henrik // Journal of Infectious Diseases;2/1/2005, Vol. 191 Issue 3, p348 

    Background. Immunological and virological consequences of low-level viremia in human immunodeficiency virus (HIV) type 1-infected patients receiving highly active antiretroviral therapy (HAART) remain to be determined. Methods. For 24 months, 101 HAART-treated, HIV-1-infected patients with HIV...

  • HIV-associated early gastric adenocarcinoma successfully cured with surgery, and followed over eight years. Manfredi, Roberto; Sabbatani, Sergio; Fasulo, Giovanni // International Journal of STD & AIDS;Jul2007, Vol. 18 Issue 7, p501 

    An extremely rare case report of HIV-associated gastric adenocarcinoma surgically treated in the year 1998 in a 37-year-old male patient already HIV positive for 10 years, with a complete post-surgery disease-free follow-up of eight years, is described. An international literature search allowed...

  • Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients. Khanlou, Homayoun; Yeh, Vivian; Guyer, Bill; Farthing, Charles // AIDS Patient Care & STDs;Mar2005, Vol. 19 Issue 3, p135 

    Previous investigational data using abacavir (ABC), lamuvidine (3TC), and zidovudine has suggested the possibility of triple nucleoside analogue reverse transcriptase inhibitors (NRTI) therapy as an option in the treatment of HIV infection. We performed a pilot study to assess the potency of...

  • Three-Class Antiretroviral Resistance in a Patient with Acute HIV-1 Infection. Gentz, Mark; Levin, Todd P.; Klibanov, Olga M.; Feingold, Anat; Condoluci, David V. // AIDS Patient Care & STDs;Nov2006, Vol. 20 Issue 11, p741 

    Antiretroviral resistance in treatment-naïve patients with HIV-1 infection is on the rise in both resource-rich and resource-poor countries. We report a case of three-class primary antiretroviral resistance detected by a genotypic assay in a 19-year-old woman with acute HIV-1 infection. Her...

  • South Africans Win Some, Lose Some. Houlton, Sarah // Pharmaceutical Executive;Oct2003, Vol. 23 Issue 10, p24 

    Reports that the South African government has approved the provision of antiretroviral drugs to HIV-positive South Africans. Funding by the Global Fund to Fight AIDS, Malaria and Tuberculosis of an AIDS program in KwaZulu Natal.

  • Human Immunodeficiency Virus (HIV) and endodontics: a review. Bürklein, Sebastian; Schäfer, Edgar // Endodontic Practice Today;2007, Vol. 1 Issue 1, p37 

    Due to the introduction of highly active antiretroviral therapy (HAART), HIV infection has gradually become more of a chronic immunodeficiency disease. In response to HAART, the CD4 cell count, in most cases, increases and thereby the HIV-infected patients are at a lower risk of developing...

  • Viral and Latent Reservoir Persistence in HIV-1--Infected Patients on Therapy. Hwijin Kim; Perelson, Alan S. // PLoS Computational Biology;Oct2006, Vol. 2 Issue 10, p1232 

    Despite many years of potent antiretroviral therapy, latently infected cells and low levels of plasma virus have been found to persist in HIV-infected patients. The factors influencing this persistence and their relative contributions have not been fully elucidated and remain controversial....

  • Sharp fall in rates of second treatment failure and death after second failure.  // HIV Treatment ALERTS!;Apr2010, p32 

    The article discusses the study conducted in 1996 through 2005 regarding the rates of second treatment failure in people with HIV in the U.S. and Canada. It says that the study covers the assessment of HIV-infected people ages 18 above who underwent antiretroviral therapy wherein their first...

  • Decreasing HIV Drug Resistance in the United Kingdom.  // Clinical Infectious Diseases;9/1/2007, Vol. 45 Issue 5, pvi 

    The article discusses the study "A decreasing prevalence of antiretroviral drug resistance in the UK: evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom." In the study, the researchers conducted analysis of major resistance mutations to determine time-dependent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics